Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by dimar66on Mar 19, 2009 2:31pm
288 Views
Post# 15856273

eventual buyout?

eventual buyout?People keep saying that RBM is going to taken over or bought out, perhaps by Roch or 3M.  I think we must consider that  both of these players know the old adage "you don't need to buy the cow to get the milk". Certainly it is quite likely that eventually new technlogy will come along that will surpass Ramp.  Our "friends" at Roche or 3M are likely to move on, unless RBM has a development pipeline which includes promising new testing platforms, which we don't right now.

RBM once had a research initiative to do prostate testing but gave it up.  Here is a good article updating where this is at in terms of clinical usefulness, it seems the right decision was not to go ahead with the PSA marker.
https://www.cnn.com/2009/HEALTH/03/16/prostate.cancer.screening/index.html

JMHO
~~ dimar
Bullboard Posts